Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls. / Knudsen, Andreas D.; Bouazzi, Randa; Afzal, Shoaib; Gelpi, Marco; Benfield, Thomas; Høgh, Julie; Thomsen, Magda Teresa; Trøseid, Marius; Nordestgaard, Børge G.; Nielsen, Susanne D.
In: BMC Infectious Diseases, Vol. 22, No. 1, 451, 12.2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls
AU - Knudsen, Andreas D.
AU - Bouazzi, Randa
AU - Afzal, Shoaib
AU - Gelpi, Marco
AU - Benfield, Thomas
AU - Høgh, Julie
AU - Thomsen, Magda Teresa
AU - Trøseid, Marius
AU - Nordestgaard, Børge G.
AU - Nielsen, Susanne D.
N1 - Funding Information: This work was supported by The Danish Heart Foundation, Novo Nordisk foundation, Augustinus Foundation, Gilead Sciences, Lundbeck foundation and Rigshospitalet Research Council. Funding Information: A.D.K has received a grant from The Danish Heart Foundation and a travelling grant from Gilead unrelated to this manuscript; S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead. Advisory board activity for Gilead and GSK/ViiV, all unrelated to this manuscript. All other authors report no conflicts of interest. Publisher Copyright: © 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: Monocytes play an important role in inflammation, and monocytosis and monocyte activation are features of chronic inflammation. We aimed to investigate if HIV status was associated with monocyte count and monocyte activation and to assess the relationship between monocyte count and monocyte activation markers and HIV-related factors. Methods: Persons living with HIV (PLWH) with measured monocyte count and sCD14 and sCD163 were included from the Copenhagen Comorbidity in HIV infection (COCOMO) study and matched 1:5 on sex and age with uninfected controls. In addition, 74 uninfected individuals from COCOMO with measured sCD14 and sCD163 were included. Identical protocols and equipment were used to determine monocyte counts and monocyte activation in PLWH and uninfected controls. Linear regression adjusted for age, sex, smoking and waist-to-hip-ratio was used to analyze the association between possible risk factors and monocyte outcomes. Results: We included 871 PLWH and 4355 uninfected controls. PLWH had − 0.021 [− 0.031 − 0.011] × 109/L) lower monocyte count than uninfected controls, and in adjusted analyses HIV status was independently associated with − 0.035 [− 0.045, − 0.025] × 109/L lower monocyte count. In contrast, PLWH had higher sCD163 and sCD14 concentrations than uninfected controls. After adjustment, HIV-status was associated with higher sCD14 and sCD163 concentrations (588 [325, 851] ng/ml, and 194 [57, 330] ng/ml, respectively). Conclusion: PLWH had lower monocyte counts than controls, but the absolute difference was small, and any clinical impact is likely limited. In contrast, concentrations of monocyte activation markers, previously implicated as drivers of non-AIDS comorbidity, were higher in PLWH than in controls.
AB - Background: Monocytes play an important role in inflammation, and monocytosis and monocyte activation are features of chronic inflammation. We aimed to investigate if HIV status was associated with monocyte count and monocyte activation and to assess the relationship between monocyte count and monocyte activation markers and HIV-related factors. Methods: Persons living with HIV (PLWH) with measured monocyte count and sCD14 and sCD163 were included from the Copenhagen Comorbidity in HIV infection (COCOMO) study and matched 1:5 on sex and age with uninfected controls. In addition, 74 uninfected individuals from COCOMO with measured sCD14 and sCD163 were included. Identical protocols and equipment were used to determine monocyte counts and monocyte activation in PLWH and uninfected controls. Linear regression adjusted for age, sex, smoking and waist-to-hip-ratio was used to analyze the association between possible risk factors and monocyte outcomes. Results: We included 871 PLWH and 4355 uninfected controls. PLWH had − 0.021 [− 0.031 − 0.011] × 109/L) lower monocyte count than uninfected controls, and in adjusted analyses HIV status was independently associated with − 0.035 [− 0.045, − 0.025] × 109/L lower monocyte count. In contrast, PLWH had higher sCD163 and sCD14 concentrations than uninfected controls. After adjustment, HIV-status was associated with higher sCD14 and sCD163 concentrations (588 [325, 851] ng/ml, and 194 [57, 330] ng/ml, respectively). Conclusion: PLWH had lower monocyte counts than controls, but the absolute difference was small, and any clinical impact is likely limited. In contrast, concentrations of monocyte activation markers, previously implicated as drivers of non-AIDS comorbidity, were higher in PLWH than in controls.
KW - Chronic inflammation
KW - HIV
KW - Monocyte activation markers
KW - Monocytes
KW - Monocytopenia
KW - Soluble CD14
KW - Soluble CD163
U2 - 10.1186/s12879-022-07450-y
DO - 10.1186/s12879-022-07450-y
M3 - Journal article
C2 - 35546661
AN - SCOPUS:85130633525
VL - 22
JO - B M C Infectious Diseases
JF - B M C Infectious Diseases
SN - 1471-2334
IS - 1
M1 - 451
ER -
ID: 321709335